| |
|
Headlines:
|
 |
Back to Oncology Labs
CA 19–9
Initially found in colorectal cancer patients, CA 19–9 has also been
identified in patients with pancreatic, stomach, and bile duct cancer.
Researchers have discovered that, in those who have pancreatic cancer,
higher levels of CA 19–9 tend to be associated with more advanced
disease. Noncancerous conditions that may elevate CA 19–9 levels
include gallstones, pancreatitis, cirrhosis of the liver, and
cholecystitis.
|
|
|
|
Are you a doctor or a nurse?
Do you want to join the Doctors Lounge online medical community?
Participate in editorial activities (publish, peer review, edit) and
give a helping hand to the largest online community of patients.
Click on the link below to see the requirements:
Doctors Lounge Membership
Application |
|
|
|
send
to a friend
printer
friendly version
